首页> 外国专利> Procedure for preparation of endocrine gene 2 (EDG-2, EDG2) receptor inhibitors for treatment of cardiovascular diseases, myocardial failure, myocardial infarction, myocardial infarction, myocardial infarction modification Myocardium, vascular remodeling, myocardial hypersensitivity and hypertension.

Procedure for preparation of endocrine gene 2 (EDG-2, EDG2) receptor inhibitors for treatment of cardiovascular diseases, myocardial failure, myocardial infarction, myocardial infarction, myocardial infarction modification Myocardium, vascular remodeling, myocardial hypersensitivity and hypertension.

机译：制备内分泌基因2（EDG-2，EDG2）受体抑制剂的程序，用于治疗心血管疾病，心肌衰竭，心肌梗塞，心肌梗塞，心肌梗塞改变，心肌，血管重塑，心肌超敏反应和高血压。

页面导航

摘要
著录项
相似文献

摘要

Compounds derived from cyclic substituted acylamino carboxylic acid; Preparation procedure; Pharmaceutical Composition and its use for treating cardiovascular diseases,Cardiomyopathy, congestive heart failure, myocardial infarction, Myocardial remodeling, vascular remodeling and hypertension, among others.

机译：衍生自环状取代的酰基氨基羧酸的化合物;准备程序;药物组合物及其在治疗心血管疾病，心肌病，充血性心力衰竭，心肌梗塞，心肌重塑，血管重塑和高血压等方面的用途。

著录项

公开/公告号CL2012001142A1

专利类型
公开/公告日2012-08-31

原文格式PDF
申请/专利权人 SANOFI;
展开▼

申请/专利号CL20120001142
发明设计人 KLEEMANN HEINZ-WERNER;PERNERSTORFER JOSEF;SCHAEFERMATTHIAS;SAFAROVA ALENA;PATEK MARCEL.;
展开▼

申请日2012-04-30
分类号A61K31/4412;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/04;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P27/00;A61P29/00;A61P3/00;A61P35/00;A61P37/00;A61P37/08;A61P5/00;A61P5/14;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P9/12;C07D213/16;
国家 CL
入库时间 2022-08-21 17:25:21

相似文献

专利
外文文献
中文文献